IP Search Results
Explore HKBU Intellectual Property
to meet your business needs and drive business growth
to meet your business needs and drive business growth
Your Search Results
SUBSTRATES OF AKR1B1/AKR1B10 AS ANTI-CANCER DRUGS
KTO Reference No.
A61-ZS-AKR1-US01
Application No.
15/772,579
Status
Published
Priority Date
2015-11-04
Filing Date
2016-11-03
Applicants
Beijing Normal University; HKBU; United International College
Inventor(s)
Stephen CHUNG; Shiqing ZHANG
Inventor(s) (Chi)
Stephen CHUNG; 張世卿
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
School/Faculty
Faculty of Science (SCI)
Department
Department of Biology (BIOL)
Anti-cancer and Anti-obesity Cyclic Peptide Agents
KTO Reference No.
A61-ZH-Obes-US01
Application No.
13/804,276
Patent No.
9,499,586
Status
Granted
Priority Date
2012-10-16
Filing Date
2013-03-14
Applicants
HKBU
Inventor(s)
Hongjie ZHANG
Inventor(s) (Chi)
張宏杰
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
School/Faculty
School of Chinese Medicine (SCM)
Cycloheptapeptide Agents for Treatment of Cancer and Obesity Diseases
KTO Reference No.
A61-ZH-Obes-US02
Application No.
15/293,516
Patent No.
9,963,485
Status
Granted
Priority Date
2012-10-16
Filing Date
2016-10-14
Applicants
HKBU
Inventor(s)
Hongjie ZHANG
Inventor(s) (Chi)
張宏杰
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
School/Faculty
School of Chinese Medicine (SCM)
Anti-cancer and Anti-obesity Cyclic Peptide Agents
KTO Reference No.
A61-ZH-Obes-EP01
Application No.
13846540.6
Patent No.
EP 2909227
Status
Granted
Priority Date
2012-10-16
Filing Date
2013-10-16
Applicants
HKBU
Inventor(s)
Hongjie ZHANG
Inventor(s) (Chi)
張宏杰
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
European Procedure (Patents)
School/Faculty
School of Chinese Medicine (SCM)
Anti-cancer and Anti-obesity Cyclic Peptide Agents
抗癌和抗肥胖的環狀肽劑
KTO Reference No.
A61-ZH-Obes-CN01
Application No.
201380048848.5
Patent No.
ZL 201380048848.5
Status
Granted
Priority Date
2012-10-16
Filing Date
2013-10-16
Applicants
HKBU
Inventor(s)
Hongjie ZHANG
Inventor(s) (Chi)
張宏杰
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
Chinese Mainland
School/Faculty
School of Chinese Medicine (SCM)
Anti-Cancer Agents Synthesized Based on Miliusane Compounds
KTO Reference No.
A61-ZH-Mili-US01
Application No.
13/831,997
Patent No.
9,211,333
Status
Granted
Priority Date
2012-06-05
Filing Date
2013-03-15
Applicants
HKBU
Inventor(s)
Hongjie ZHANG
Inventor(s) (Chi)
張宏杰
Technology Area
Biotechnology & Chinese Medicine
Jurisdiction
United States Of America
School/Faculty
School of Chinese Medicine (SCM)
Advanced Search